Biggest News Aggregation in the World
📰 Phra News

Page 20 - Phra News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phra. Real-time updates on events, politics, business and more.

BeiGene: BRUKINSA (zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukemia (CLL) and Marginal Zone Lymphoma (MZL) in Great Britain by MHRA

MHRA marketing authorizations follow recent European Commission marketing authorizations BRUKINSA is the only treatment authorized for MZL in Great Britain BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE:
United States United Kingdom South Korea Northern Ireland Great Britain Mehrdad Mobasher

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science